Storia in 2 fonti

Compass says depression drug has long-lasting benefits

Vertex makes its largest-ever deal, skyrocketing health insurance costs, and more biotech news from The Readout

Raccontata da

statnews.com

fiercepharma.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

statnews.comStai leggendo1 mese fa

Compass says depression drug has long-lasting benefits

Vertex makes its largest-ever deal, skyrocketing health insurance costs, and more biotech news from The Readout

originale

fiercepharma.com1 mese fa

Vertex, in its largest-ever deal, acquires endocrine disease specialist Crinetics for $10B

Vertex Pharmaceuticals has struck a $10 billion deal—its largest ever—to acquire | Vertex Pharmaceuticals has struck a $10 billion deal—its largest ever—to acquire endocrine disease specialist Crinetics Pharmaceuticals.…

Leggi questa versione → originale

Timeline cronologica

lunedì 6 luglio 2026·statnews.com
Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms
Vertex Pharmaceuticals will spend $10 billion to acquire Crinetics Pharmaceuticals and its drug for a rare endocrine disorder, the companies announced.
martedì 7 luglio 2026·fiercepharma.com
Vertex, in its largest-ever deal, acquires endocrine disease specialist Crinetics for $10B
Vertex Pharmaceuticals has struck a $10 billion deal—its largest ever—to acquire | Vertex Pharmaceuticals has struck a $10 billion deal—its largest ever—to acquire endocrine…

Compass says depression drug has long-lasting benefits

Vertex, in its largest-ever deal, acquires endocrine disease specialist Crinetics for $10B

Timeline cronologica

Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms

Vertex, in its largest-ever deal, acquires endocrine disease specialist Crinetics for $10B

Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and more

Compass says depression drug has long-lasting benefits